HER2/neu expression in bladder cancer: relationship to cell cycle kinetics

被引:26
|
作者
Eissa, S [1 ]
Ali, HS
Al Tonsi, AH
Zaglol, A
El Ahmady, O
机构
[1] Ain Shams Univ, Fac Med, Dept Biochem, Oncol Diagnost Unit, Cairo, Egypt
[2] Zagazig Univ, Benha Fac Med, Dept Biochem, Zagazig, Egypt
[3] NCI, Dept Surg Oncol, Giza, Egypt
[4] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt
关键词
HER2/neu; SPF; DI; ploidy; bladder cancer;
D O I
10.1016/j.clinbiochem.2004.09.004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background and objectives: The incidence of overexpression of HER2/neu in bladder cancer is one of the highest among all human malignancies tested; such overexpression is thought to play a role in the aberrant proliferation of cancer cells. This study was conducted to evaluate the quantitative assessment of HER2/neu expression by enzyme immunoassay (ETA) and its prognostic significance in differentiating between high and low proliferating tumors. Patients and methods: Tissue samples were collected from 35 patients with benign bladder lesions, 28 with bilharzial bladder cancer, and 25 with nonbilharzial bladder cancer. Twenty normal samples were obtained from normal safety margin areas in nonbilbarzial bladder cancer patients. Out of the malignant samples, 22 were found to be squamous cell carcinoma and 31 were transitional cell carcinoma. All samples were examined for HER2/neu expression by EIA and Western blot (WB). Flow cytometric (FCM) analysis was also performed in all the samples provided. Results: HER2/neu was found to be significantly overexpressed in the malignant group compared to the benign and normal groups (P < 0.001) and no significant difference was found between the bilharzial and nonbilharzial cancer groups or between the transitional and squamous cell carcinoma groups. HER2/neu was significantly correlated to ploidy (P = 0.001), synthetic phase fraction, SPF (P = 0.012), and DNA index (P = 0.002). No significant correlation was found between HER2/neu and stage or grade while it was significantly associated with lymph node status of the tumour (P = 0.02). Conclusion: HER2/neu can be measured reliably by the EIA method as confirmed by WB. The quantitative assessment of HER2/neu expression in malignant tumors aided by other proliferation markers such as SPF, DI, and ploidy could be useful in selecting patients for more aggressive treatment or for predicting outcome. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 50 条
  • [1] Cox-2 and Her2/neu co-expression in invasive bladder cancer
    Eltze, E
    Wülfing, C
    Von Struensee, D
    Piechota, H
    Buerger, H
    Hertle, L
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (06) : 1525 - 1531
  • [2] HER2/NEU PROTEIN EXPRESSION IN COLORECTAL CANCER
    Andrews, Nimmy
    Letha, V
    Sankar, S.
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (06): : 341 - 345
  • [3] Expression of Her2/neu in locally advanced bladder cancer:: Implication for a molecular targeted therapy
    Wülfing, C
    von Struensee, D
    Bierer, S
    Bögemann, M
    Hertle, L
    Eltze, E
    [J]. AKTUELLE UROLOGIE, 2005, 36 (05) : 423 - 429
  • [4] Prognostic significance of HER2/neu expression in gastric cancer
    Ananiev, Julian
    Gulubova, Maya
    Manolova, Irena
    Tchernev, Georgi
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (13-14) : 450 - 454
  • [5] HER2/neu expression in cancer: The pathologist as diagnostician or prophet?
    Foster, CS
    Gosden, CM
    Ke, YQ
    [J]. HUMAN PATHOLOGY, 2003, 34 (07) : 635 - 638
  • [6] HER2 expression in primary bladder tumors and paired regional lymph nodes: Relationship to cell cycle profile
    Dumitru, M.
    Mihaila, M.
    Hotnog, C. M.
    Panait, M. E.
    Vasilescu, M. M.
    Hortopan, M. G.
    Brasoveanu, L. I.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1369 - S1370
  • [7] Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer
    Tambo, Mitsuhiro
    Higashihara, Eiji
    Terado, Yuichi
    Nutahara, Kikuo
    Okegawa, Takatsugu
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (04) : 369 - 374
  • [8] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    [J]. TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [9] Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu
    Roh, H
    Pippin, J
    Drebin, JA
    [J]. CANCER RESEARCH, 2000, 60 (03) : 560 - 565
  • [10] Expression of HER2/NEU in Different Grades of Urothelial Carcinoma of Urinary Bladder
    Sarfraz, Muhammad Kashif
    Anwar, Umbereen
    Alam, Ameer
    Rizwan, Muhammad
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 745 - 746